Press release
Cancer Biomarkers Market Outlook to 2027 - QIAGEN, Illumina, GENERAL ELECTRIC COMPANY, bioMérieux, Creative Diagnostics, Hologic
The Insight Partners
Rise in the number of cancer cases as well as increasing research and development activities is anticipated to drive the growth of the cancer biomarkers market. Rising awareness regarding personalized medicine is expected to offer significant growth opportunities in the market in the coming years.
Cancer biomarkers are the molecules that help in the diagnosis as well as the treatment of various forms of cancer. These molecules are produced by the cancer tissue or by other cells in the body in response to cancer. These molecules can be monitored by obtaining samples such as, blood, stool, urine, tumor tissue, or other tissues or bodily fluids.
Key Players operating in the cancer biomarkers market include, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., QIAGEN, Illumina, Inc., GENERAL ELECTRIC COMPANY, bioMérieux, Inc., Creative Diagnostics, Hologic Inc., and Quest Diagnostics among others.
Get Sample Copy at https://www.theinsightpartners.com/sample/TIPBT00002663
The "Global Cancer biomarkers Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global market with detailed market segmentation by product, application, end user, and geography. The global cancer biomarkers market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
The global cancer biomarkers market is segmented on the basis of biomarker type, profiling technology, cancer type, and application. on the basis of biomarker type, the cancer biomarkers market is segmented as, genetic biomarkers, protein biomarkers and other cancer biomarkers. The segment of genetic biomarkers is further classified as, leukemia, lung cancer, breast cancer, and prostate cancer. On the basis of profiling technology, the market is segmented as, omics technologies, imaging technologies, immunoassays, cytogenetics, and bioinformatics.
The omics technologies is further categorized as, proteomics and genomics. Imaging technologies are classified as, ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), and mammography. The cancer biomarkers market is classified based on cancer types such as, breast cancer, lung cancer, prostate cancer, leukemia, bladder cancer, and other cancer types. On the basis of application, the market is segmented as, diagnostics, research and development, prognostics, and other applications.
Browse Complete Report at https://www.theinsightpartners.com/reports/cancer-biomarkers-market
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global cancer biomarkers market based on biomarker type, profiling technology, cancer type, and application. It also provides market size and forecast till 2027 for overall market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The cancer biomarkers market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.
North America is expected to contribute to the largest share in the cancer biomarkers market in the coming years, owing to rising incidence of cancer. Asia Pacific is expected to witness significant growth during the forecast period, due to increase in the number of R&D activities being conducted in the field of cancer therapy.
The report analyzes factors affecting cancer biomarkers market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Cancer biomarkers market in these regions.
Get 20% Discount on Purchase Till 10 Jan 2019 - https://www.theinsightpartners.com/buy/TIPBT00002663/
About Us - The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Healthcare IT, Biotechnology and Medical Device industries.
Contact us -
Contact Person : Sameer Joshi
Phone : +1-646-491-9876
Email Id : sam@theinsightpartners.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Biomarkers Market Outlook to 2027 - QIAGEN, Illumina, GENERAL ELECTRIC COMPANY, bioMérieux, Creative Diagnostics, Hologic here
News-ID: 1450439 • Views: …
More Releases from The Insight Partners
Orthopedic 3D Scanners Market Is Gaining Huge Growth In Upcoming Years
3D orthopaedic scanning devices are sophisticated technology-driven systems used to scan human body components for the detection and treatment of the defect. By means of its scanning capabilities, 3D orthopaedic scanning systems help to design uniquely customised products and to find further use in surgical procedures.
Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00017457/?utm_source=OpenPR&utm_medium=10129
Orthopedic 3D Scanners Market: Competitive Landscape and Key Developments:
• Delcam Plc
• Allied OSI Labs
• SCANNY3D S.r.l.
• AGE Solutions S.r.l.
• Orthopaedic Innovation Centre
• Diasu…
Prostate Cancer Diagnostics: A Guide to Understanding the Process
Prostate cancer diagnostics refers to the various tests and procedures used to diagnose prostate cancer in men. Early detection of prostate cancer is important for successful treatment and recovery. Several different diagnostic tests are available, including digital rectal exams, prostate-specific antigen (PSA) tests, and biopsies. With the increasing prevalence of prostate cancer.
Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00003656/?utm_source=OpenPR&utm_medium=10129
Prostate Cancer Diagnostics Market: Competitive Landscape and Key Developments:
• MDxHealth
• Telo Genomics Corp…
Aerospace Plastics Market Research Insights with Upcoming Trends Segmentation, O …
The Aerospace Plastics Market report by "The Insight Partners" entails detailed information regarding the dynamics affecting market valuation over the analysis period. It also covers the competitive landscape, market scope, and market segmentation.
Get Sample Copy of Report at: https://www.theinsightpartners.com/sample/TIPRE00005464/?utm_source=OpenPR&utm_medium=10188
Companies Profiled in this report includes:
• SABIC
• Victrex
• Drake Plastics Ltd
• Solvay
• BASF SE
• Evonik Industries AG
• Vantage Plane Plastics
• Paco Plastics & Engineering Inc.
• 3P
• Performance Plastics Products
• Big Bear Plastics
The report scrutinizes different business approaches and frameworks that…
Consumer Genomics: A Guide to Understanding the Process
Consumer genomics market is growing as it is very frictionless. A patient can purchase a genetic test online and then receive a test kit by mail and collect a DNA sample in their own home. Patients will receive the results at home and don't need any guidance of a genetic counselor or medical practitioner.
Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00006429/?utm_source=OpenPR&utm_medium=10129
Consumer Genomics Market: Competitive Landscape and Key Developments:
• …
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
Oncology Nutrition Market led to an unprecedented rise by 2025 : liver cancer, p …
Global Oncology Nutrition Market: Overview
Cancer diagnosis creates myriad questions about diet and nutrition. Those pertain to if the food will make a patient feel sick to what should be ingested to fight cancer. This has spawned the oncology nutrition market which has been rising steadily due to the increasing cases of different types of cancer worldwide. During cancer treatment one needs to eat right in order to build up strength…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports.
This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.
This report focuses on top…
